Inventor
BURGESS LAURENCE E
US41 patents
⚠️ This page may combine multiple inventors who share the name “BURGESS LAURENCE E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARRAY BIOPHARMA INC
14 patentsUS7169926B1Jan 30, 2007
Dipeptidyl peptidase inhibitors
ARRAY BIOPHARMA INC68 citations95
US6362216B1Mar 26, 2002
Compounds which inhibit tryptase activity
ARRAY BIOPHARMA INC29 citations92
US7226906B2Jun 5, 2007
Cyclosporin analogs for the treatment of immunoregulatory disorders and respiratory diseases
ARRAY BIOPHARMA INC7 citations73
US6586467B2Jul 1, 2003
Preparation of phosphatase inhibitors
ARRAY BIOPHARMA INC11 citations73
US10730880B2Aug 4, 2020
4,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitors
ARRAY BIOPHARMA INC4 citations71
US10189845B2Jan 29, 2019
4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors
ARRAY BIOPHARMA INC2 citations71
US8044083B2Oct 25, 2011
Kinase inhibitors and methods of use thereof
ARRAY BIOPHARMA INC5 citations71
US6221914B1Apr 24, 2001
Sulfonamide bridging compounds that inhibit tryptase activity
ARRAY BIOPHARMA INC4 citations63
US9556139B2Jan 31, 2017
6-substituted phenoxychroman carboxylic acid derivatives
ARRAY BIOPHARMA INC1 citations62
US9096567B2Aug 4, 2015
6-substituted phenoxychroman carboxylic acid derivatives
ARRAY BIOPHARMA INC2 citations62
US8716498B2May 6, 2014
6-substituted phenoxychroman carboxylic acid derivatives
ARRAY BIOPHARMA INC2 citations62
US11028093B2Jun 8, 2021
4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors
ARRAY BIOPHARMA INC0 citations61
US8026233B2Sep 27, 2011
P38 inhibitors and methods of use thereof
ARRAY BIOPHARMA INC2 citations51
US7553842B2Jun 30, 2009
Macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseases
ARRAY BIOPHARMA INC0 citations40
ICOS CORP
7 patentsUS6423710B1Jul 23, 2002
Cyclic AMP-specific phosphodiesterase inhibitors
ICOS CORP47 citations95
US6258833B1Jul 10, 2001
Cyclic AMP-specific phosphodiesterase inhibitors
ICOS CORP55 citations94
US6716871B2Apr 6, 2004
Cyclic AMP-specific phosphodie sterase inhibitors
ICOS CORP14 citations92
US6680336B2Jan 20, 2004
Cyclic AMP-specific phosphodiesterase inhibitors
ICOS CORP23 citations92
US6376489B1Apr 23, 2002
Cyclic AMP-specific phosphodiesterase inhibitors
ICOS CORP22 citations92
US6458787B1Oct 1, 2002
Cyclic AMP-specific phosphodiesterase inhibitors
ICOS CORP24 citations91
US6998416B2Feb 14, 2006
Cyclic AMP-specific phosphodiesterase inhibitors
ICOS CORP1 citations62
MIRATI THERAPEUTICS INC
4 patentsUS10125134B2Nov 13, 2018
KRas G12C inhibitors
MIRATI THERAPEUTICS INC43 citations96
US10689377B2Jun 23, 2020
KRas G12C inhibitors
MIRATI THERAPEUTICS INC16 citations85
US11267812B2Mar 8, 2022
KRAS G12C inhibitors
MIRATI THERAPEUTICS INC11 citations84
US10633381B2Apr 28, 2020
KRas G12C inhibitors
MIRATI THERAPEUTICS INC8 citations82
HOWBERT JAMES JEFFRY
3 patentsUS8691809B2Apr 8, 2014
Substituted benzoazepines as toll-like receptor modulators
HOWBERT JAMES JEFFRY8 citations82
US8524702B2Sep 3, 2013
Substituted benzoazepines as toll-like receptor modulators
HOWBERT JAMES JEFFRY6 citations81
US9718796B2Aug 1, 2017
Substituted benzoazepines as toll-like receptor modulators
HOWBERT JAMES JEFFRY0 citations39
VENTIRX PHARMACEUTICALS INC
3 patentsUS9655904B2May 23, 2017
Substituted benzoazepines as toll-like receptor modulators
VENTIRX PHARMACEUTICALS INC2 citations71
US9126940B2Sep 8, 2015
Substituted benzoazepines as toll-like receptor modulators
VENTIRX PHARMACEUTICALS INC3 citations60
US9242964B2Jan 26, 2016
Substituted benzoazepines as toll-like receptor modulators
VENTIRX PHARMACEUTICALS INC2 citations59